首页 | 本学科首页   官方微博 | 高级检索  
     

基于德尔菲法构建药物重整过程中药物差异分类工具
引用本文:杜亚玲,李欣宇,杨新惠,魏雯,张智慧,郭新红,李静,彭曦. 基于德尔菲法构建药物重整过程中药物差异分类工具[J]. 中国医院药学杂志, 2022, 42(13): 1376-1381. DOI: 10.13286/j.1001-5213.2022.13.16
作者姓名:杜亚玲  李欣宇  杨新惠  魏雯  张智慧  郭新红  李静  彭曦
作者单位:1. 石河子大学医学院第一附属医院公共卫生科, 新疆 石河子 832000;2. 重庆医科大学附属第一医院药学部, 重庆 400016;1. 石河子大学医学院第一附属医院药学部, 新疆 石河子 832000
基金项目:石河子大学医学院第一附属医院2019年院级科技计划项目(编号:GL201901);石河子大学医学院第一附属医院2021年院级科技计划立项项目(编号:BS202108)
摘    要:目的:构建药物重整过程中药物差异分类工具(Medication Discrepancy Taxonomy,MedTax),推动药物重整实施标准化。方法:翻译MedTax,运用德尔菲专家咨询法从分类的代表性、唯一性、分类名称的明确性和分类定义的清晰性四个方面对MedTax的每个二、三级分类指标进行评分。在分析专家协调系数、权威系数、内容效度和专家意见集中度的基础上,构建中文版药物差异分类工具,使用虚拟案例应用多自由边际Kappa检验可靠性。结果:经过11名专家两轮修改,构建了包含药物不匹配和药物部分匹配2个一级指标,遗漏药物、添加药物、药物重复等11个二级指标和23个三级指标的中文版药物差异分类工具。两轮专家咨询的专家权威系数均为0.85,专家协调系数分别为0.51和0.61,经χ2检验,P<0.01。第二轮专家咨询各指标均数为4.0~4.45分,变异系数为0.12~0.27,内容有效性指数为0.82~1.0,经可靠性测试,总体一致性评分为0.76。结论:该研究专家权威性可靠,专家意见集中度高,协调性好,结果可信。构建的中文版药物差异分类工具内部一致性高,可用于药物重整过程中药物差异的分类和测量。

关 键 词:药物重整  药物差异  分类  德尔菲专家咨询  
收稿时间:2021-10-29

Using the Delphi method to construct a classification taxonomy for medication discrepancies identified through medication reconciliation
DU Ya-ling,LI Xin-yu,YANG Xin-hui,WEI Wen,ZHANG Zhi-hui,GUO Xin-hong,LI Jing,PENG Xi. Using the Delphi method to construct a classification taxonomy for medication discrepancies identified through medication reconciliation[J]. Chinese Journal of Hospital Pharmacy, 2022, 42(13): 1376-1381. DOI: 10.13286/j.1001-5213.2022.13.16
Authors:DU Ya-ling  LI Xin-yu  YANG Xin-hui  WEI Wen  ZHANG Zhi-hui  GUO Xin-hong  LI Jing  PENG Xi
Affiliation:1. Public Health Division, First Affiliated Hospital, School of Medicine, Shihezi University, Xinjiang Shihezi 832000, China;2. Department of Pharmacy, First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China;3. Department of Pharmacy, First Affiliated Hospital, School of Medicine, Shihezi University, Xinjiang Shihezi 832000, China
Abstract:OBJECTIVE To construct a medication discrepancy taxonomy (MedTax) for medication reconciliation to promote the standardization of medication reconciliation.METHODS The MedTax was translated. Two rounds of Delphi method were used to score each classification index at the second level and third level of the medication discrepancies taxonomy tool from four aspects of representativeness, uniqueness, clarity of classification name, and clarity of classification definition. Based on the analysis of expert coordination coefficient, authority coefficient, content validity and concentration of expert opinions, the Chinese medication discrepancies taxonomy (C-MedTax) was constructed. Virtual cases were used to test the reliability of the C-MedTax with multi-free marginal Kappa.RESULTS After two rounds of revisions by 11 experts, the C-MedTax was constructed including two first-level indicators of drug mismatched and drug partial matched, 11 second-level indicators such as omission drugs, commission drugs, and drug duplication, and 23 third-level indicators. The expert authority coefficients of the two rounds of consultation were both 0.85, and the expert coordination coefficients were 0.51 and 0.61, respectively. Chi-square test showed P<0.01. In the second round of consultation, the mean of each index was 4.0-4.45, the coefficient of variation was 0.12-0.27, and the content validity index was 0.82-1.0. After reliability testing, the overall consistency score was 0.76, and the scorers were compared in pairs, and 85% of the consistency scores were above 0.7.CONCLUSION The experts in this study were authoritative and reliable, expert opinions were highly concentrated and coordinated, and the results were credible. The constructed medication discrepancies taxonomy has high internal consistency and can be used to measure medication discrepancies in the process of medication reconciliation.
Keywords:medication reconciliation  medication discrepancies  taxonomy  Delphi expert consultation  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号